Barclays’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4K | Sell |
1,148
-4,967
| -81% | -$17.3K | ﹤0.01% | 4232 |
|
2025
Q1 | $25K | Sell |
6,115
-2,475
| -29% | -$10.1K | ﹤0.01% | 4029 |
|
2024
Q4 | $91K | Buy |
8,590
+947
| +12% | +$10K | ﹤0.01% | 3815 |
|
2024
Q3 | $189K | Buy |
7,643
+4,764
| +165% | +$118K | ﹤0.01% | 3514 |
|
2024
Q2 | $81K | Sell |
2,879
-862
| -23% | -$24.3K | ﹤0.01% | 3477 |
|
2024
Q1 | $152K | Sell |
3,741
-3,045
| -45% | -$124K | ﹤0.01% | 3465 |
|
2023
Q4 | $112K | Buy |
6,786
+5,427
| +399% | +$89.6K | ﹤0.01% | 3691 |
|
2023
Q3 | $52K | Sell |
1,359
-381
| -22% | -$14.6K | ﹤0.01% | 3578 |
|
2023
Q2 | $95K | Sell |
1,740
-1,279
| -42% | -$69.8K | ﹤0.01% | 3418 |
|
2023
Q1 | $130K | Buy |
3,019
+1,728
| +134% | +$74.4K | ﹤0.01% | 3393 |
|
2022
Q4 | $51K | Buy |
1,291
+1,087
| +533% | +$42.9K | ﹤0.01% | 3769 |
|
2022
Q3 | $11K | Sell |
204
-49
| -19% | -$2.64K | ﹤0.01% | 4129 |
|
2022
Q2 | $17K | Sell |
253
-476
| -65% | -$32K | ﹤0.01% | 4148 |
|
2022
Q1 | $54K | Buy |
+729
| New | +$54K | ﹤0.01% | 3975 |
|